Knowledge on human papilloma virus (HPV) related genital lesions and vaccination against HPV in a sample of women of north-east Italy;Conoscenza delle patologie genitali HPV-correlate e sul vaccino anti-HPV in una popolazione femminile del nord-est Italiano

Minerva Ginecologica

Volumn 61, Issue 2, 2009, Pages 81-87

  Sopracordevole, F ^a   Cigolot, F ^b   Lucia, E ^a   Marchesoni, D ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Genitalia, female, virology; Human papillomavirus 16; Papillomavirus vaccines

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CONDYLOMA; DRUG EFFICACY; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; ITALY; KNOWLEDGE; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SEXUAL BEHAVIOR; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ITALY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SAMPLE SIZE; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 67649550848     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. IARC Working Group. Human papillomaviruses IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC; 1995.
2. Munoz N, Bosch FX, Castellsague X, Diaz M, De Sanjose S, Hammouda D et al. Against which human papillomavirus types shall we vaccinate and screen? The international prospective. Int J Cancer 2004;111:278-285 (Pubitemid 38924707)
3. Frazer JH, Cox JT, Majeaux EJ, Franco EL, Moscicki AB, Wheeler CM et al. Advances in prevention of cervical cancer and other HPV-related disease. Ped Infect Dis J 2006;25:565-581
4. Arbyn M, Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for quality assurance in cervical cancer screening. J Clin Virol 2007;38:189-197 (Pubitemid 46275523)
5. Paavonen J, Jenkins D, Bosh FX, Naud P, Salmeron J, Wheeler CM et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like particle vaccine against infection with HPV 16 and 18 in young women: an interim analysis of a phase III double-blind, RCT. Lancet 2007;369:2160-2170 (Pubitemid 46977438)
6. The Future II Study Group. Quadrivalent vaccine against Human Papillomavirus to prevent high-grade cervical lesion. New Engl J Med 2007;356:1915-1927
7. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6,11,16 and 18) L1 virus-like particke vaccine against high-grade vulval and vaginal lesions: a combined analysis of 3 randomised clinical trias. Lancet 2007;369:1693-1702
8. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with HPV types 16 and 18 in young women: a RCT. Lancet 2004;364:1757-1765
9. Harper DM, Franco EL, Wheeler C, Moscicki AB, Romanowski B, Roteli-Martins CM. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against HPV types 16 and 18: follow up from a RCT. Lancet 2006;367:1247-1255
10. WHO/UNPFA Preparing for the introduction of HPV vaccines, policy and program guidance for countries. World Health Organization 2006.
11. American Cancer Society Guidelines for HPV vaccine use to prevent cervical cancer and its precursors. Cancer J Clin 2007;57:7-28. (Pubitemid 46148088)
12. WHO. Vaccine introduction guidelines: adding a vaccine to a national immunization programme. Decision and implementation. 2005; WHO/IVB/0.5.18.
13. AIFA. Ministero della Salute. BIF 14 n. 1 2007.
14. Consiglio Superiore di Sanità Sessione XLVI, sezioni congiunte II e III, seduta dell'11 gennaio 2007.
15. Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer 2008;99:225-229
16. Nohr B, Munk C, Tryggvadottir L, Sparen P, Tran TN, Nygard M et al. Awareness of human papillomavirus in a cohort of nearly 70,000 women from Nordic countries. Acta Obstet Gynecol Scand 2008;87:1048-1054
17. Bair RM, Mays RM, Sturm LA, Zimet GD. Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol 2008;21:329-334
18. Noakes K, Yarwood J, Salisbury D. Parental response to the introduction of a vaccine against human papillomavirus. Hum Vaccin 2006;2:243-248 (Pubitemid 46025655)
19. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human Papillomavirus vaccine. J Adolesc Health 2005;37:248-251 (Pubitemid 41139956)
20. Pitts M, Clarke T. Human Papillomavirus infections and risks of cervical cancer: What do woman know? Health Educ Res 2002;17:706-714
21. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among woman attendine a well woman clinic. Sex Transm Infect 2003;79:320-322 (Pubitemid 37026352)
22. Holcomb B, Bailey JM, Crawford K, Ruffin MT. Adult's knowledge and behaviours related to human papillomavirus infection. J Am Board Fam Pract 2004;17:26-31.
23. Kollar LM, Kahn TA. Education about human papillomavirus and human papillomavirus vaccines in adolescents. Curr Opin Obstet Gynecol 2008;20:479-483
24. Anhang R, Wright TC, Smock L, Goldie SJ. Women's desired information about human papillomavirus. Cancer 2004;100:315-320 (Pubitemid 38063640)
25. Allen JD, Mohllajee AP, Shelton RC, Othus MK, Fontenot H, Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2008 [Epub ahead of printing].
26. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson E. Public knowledge and attitudes towards HPV vaccination. BMC Public Health 2008;8:368.
27. Esposito S, Bosis S, Pilucchi C, Begliatti E, Rognoni A, Bellasio M et al. Pediatrician and attitudes regarding human papillomavirus disease and its prevention. Vacine 2007;25:6437-6446 (Pubitemid 47202049)
28. Winkler JL, Wittet S, Bartolini RM, Creed Kanashiro HM, Lazcano-Ponce E, Lewis-Bell K et al. Determinants oh human papillomavirus vaccine acceptability in Latin America and the Carribbean. Vaccine 2008;11:L73-9.